GSK-3β gene expression in human postmortem brain: Regional distribution, effects of age and suicide

Neurochemical Research

Volumn 34, Issue 2, 2009, Pages 274-285

  Pandey, Ghanshyam N ^a   Dwivedi, Yogesh ^a   Rizavi, Hooriyah S ^a   Teppen, Tara ^a   Gaszner, Gabor L ^a   Roberts, Rosalinda C ^b   Conley, Robert R ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

GSK 3 ; Hippocampus; Postmortem brain; Prefrontal cortex; Suicide; Teenage

Indexed keywords

MESSENGER RNA; CYCLOPHILIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PRIMER DNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BRAIN; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3BETA GENE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUICIDE; AGING; CADAVER; CASE CONTROL STUDY; CAUSE OF DEATH; ENZYMOLOGY; GENETICS; MENTAL DISEASE; METABOLISM;

ADOLESCENT; ADULT; AGING; BASE SEQUENCE; BRAIN; CASE-CONTROL STUDIES; CAUSE OF DEATH; CYCLOPHILINS; DNA PRIMERS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MENTAL DISORDERS; POSTMORTEM CHANGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUICIDE;

EID: 58849159681     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9770-1     Document Type: Article

References (49)

1. EK Moscicki P O'Carroll DS Rae BZ Locke A Roy DA Regier 1988 Suicide attempts in the Epidemiologic Catchment Area Study Yale J Biol Med 61 259 268
2. AM Minino BL Smith 2001 Deaths: preliminary data for 2000 Natl Vital Stat Rep 49 1 40
3. Botsis AF, Soldatos CR, Stefanis CN (1997) Suicide: biopsychological approaches. Elsevier, Amsterdam
4. EC Harris B Barraclough 1997 Suicide as an outcome for mental disorders. A meta-analysis Br J Psychiatry 170 205 228
5. RC Kessler KA McGonagle S Zhao 1994 Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch Gen Psychiatry 51 8 19
6. Lönqvist J (2000) Psychiatric aspects of suicidal behavior: Depression. In: von Heeringen K, Hawton K (eds) The International Handbook of Suicide and Attempted Suicide. Wiley, Chichester, UK, pp 107-120
7. E Moscicki 1977 Identification of suicide risk factors using epidemiologic studies Psychiatr Clin North Am 20 499 517
8. DA Regier ME Farmer DS Rae 1993 One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study Acta Psychiatr Scand 88 35 47
9. R Gross-Isseroff A Biegon H Voet A Weizman 1998 The suicide brain: a review of postmortem receptor/transporter binding studies Neurosci Biobehav Rev 22 653 661
10. GN Pandey Y Dwivedi HS Rizavi 2002 Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims Am J Psychiatry 159 419 429
11. MA Pacheco C Stockmeier HY Meltzer JC Overholser GE Dilley RS Jope 1996 Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain Brain Res 723 37 45
12. Y Dwivedi JS Rao HS Rizavi 2003 Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects Arch Gen Psychiatry 60 273 282
13. Y Dwivedi HS Rizavi RR Conley RC Roberts CA Tamminga GN Pandey 2002 mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims Neuropsychopharmacology 27 499 517
14. RS Jope L Song CA Grimes 1998 Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence J Neurochem 70 763 771
15. Y Dwivedi HS Rizavi PK Shukla 2004 Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits Biol Psychiatry 55 234 243
16. GN Pandey Y Dwivedi SC Pandey RR Conley RC Roberts CA Tamminga 1997 Protein kinase C in the postmortem brain of teenage suicide victims Neurosci Lett 228 111 114
17. GN Pandey Y Dwivedi HS Rizavi X Ren RR Conley 2004 Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study Arch Gen Psychiatry 61 685 693
18. CA Grimes RS Jope 2001 The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling Prog Neurobiol 65 391 426
19. TC Dale 1998 Signal transduction by the Wnt family of ligands Biochem J 329 Pt 2 209 223
20. A Wodarz R Nusse 1998 Mechanisms of Wnt signaling in development Annu Rev Cell Dev Biol 14 59 88
21. A Patapoutian LF Reichardt 2000 Roles of Wnt proteins in neural development and maintenance Curr Opin Neurobiol 10 392 399
22. J Behrens BA Jerchow M Wurtele 1998 Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta Science 280 596 599
23. RT Moon JD Brown M Torres 1997 WNTs modulate cell fate and behavior during vertebrate development Trends Genet 13 157 162
24. PC Shaw AF Davies KF Lau 1998 Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes Genome 41 720 727
25. JR Woodgett 1990 Molecular cloning and expression of glycogen synthase kinase-3/factor A EMBO J 9 2431 2438
26. C Beasley D Cotter N Khan 2001 Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia Neurosci Lett 302 117 120
27. D Cotter R Kerwin S al-Sarraji 1998 Abnormalities of Wnt signalling in schizophrenia-evidence for neurodevelopmental abnormality Neuroreport 9 1379 1383
28. N Kozlovsky RH Belmaker G Agam 2000 Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients Am J Psychiatry 157 831 833
29. C Nadri B Dean E Scarr G Agam 2004 GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients Schizophr Res 71 377 382
30. M Lesort A Greendorfer C Stockmeier GV Johnson RS Jope 1999 Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain J Neural Transm 106 1217 1222
31. PS Klein DA Melton 1996 A molecular mechanism for the effect of lithium on development Proc Natl Acad Sci USA 93 8455 8459
32. V Stambolic L Ruel JR Woodgett 1996 Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells Curr Biol 6 1664 1668
33. HK Manji JM Bebchuk GJ Moore D Glitz KA Hasanat G Chen 1999 Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications J Clin Psychiatry 60 Suppl 2 27 39 discussion 40-1, 113-6
34. Salzman S, E.J., Clayton P, Winokur G (1983) Diagnostic Evaluation After Death (DEAD). National Institute of Mental Health Neuroscience Research Branch, Rockville
35. RL Spitzer JB Williams M Gibbon MB First 1992 The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description Arch Gen Psychiatry 49 624 629
36. Y Dwivedi HS Rizavi RR Conley RC Roberts CA Tamminga GN Pandey 2003 Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects Arch Gen Psychiatry 60 804 815
37. K Leroy JP Brion 1999 Developmental expression and localization of glycogen synthase kinase-3beta in rat brain J Chem Neuroanat 16 279 293
38. N Kozlovsky C Nadri G Agam 2005 Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult Eur Neuropsychopharmacol 15 1 11
39. C Nadri BK Lipska N Kozlovsky DR Weinberger RH Belmaker G Agam 2003 Glycogen synthase kinase (GSK)-3beta levels and activity in a neurodevelopmental rat model of schizophrenia Brain Res Dev Brain Res 141 33 37
40. LG Fradkin G Garriga PC Salinas JB Thomas X Yu Y Zou 2005 Wnt signaling in neural circuit development J Neurosci 25 10376 10378
41. L Ciani PC Salinas 2005 WNTs in the vertebrate nervous system: from patterning to neuronal connectivity Nat Rev Neurosci 6 351 362
42. GN Bijur RS Jope 2001 Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta J Biol Chem 276 37436 37442
43. M Pap GM Cooper 1998 Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway J Biol Chem 273 19929 19932
44. L Mai RS Jope X Li 2002 BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents J Neurochem 82 75 83
45. HK Manji GJ Moore G Chen 2000 Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness J Clin Psychiatry 61 Suppl 9 82 96
46. O Kaidanovich-Beilin A Milman A Weizman CG Pick H Eldar-Finkelman 2004 Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus Biol Psychiatry 55 781 784
47. C Beasley D Cotter I Everall 2002 An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder Schizophr Res 58 63 67
48. F Karege N Perroud S Burkhardt 2007 Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims Biol Psychiatry 61 240 245
49. RS Jope 2003 Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes Trends Pharmacol Sci 24 441 443